MPDD Device Gaining Popularity with Patients and Doctors,

New Post Public Reply Private Reply Replies (0) Message Board
steelerfan7

MPDD Device Gaining Popularity with Patients and Doctors, Marketed by EPGL Medical and EP Global Communications, Inc.

A growing number of patients and doctors are believers in a new way to treat pain

Irvine, CA (PRWEB) April 24, 2013

EP Global Communications, Inc. (the Company), (Stock Ticker: EPGL) released the MPDD medical device for the treatment of chronic pain just last month. The device, which has been in development for several years, had not been made available to the open market until March 2013. Several doctors and patients involved in research and within clinical settings have known about the successful outcomes which were made possible by the MPDD device.

Now, as the FDA cleared MPDD has finally been made available for doctors to purchase, the early experiences by both doctors and patients is continuing to show excellent results. People who thought they had no hope of attaining lasting relief from chronic back, neck, and other pain, are becoming fans of the device quickly. "Let's just say that I'm using it on a daily basis on well over 50% of my patients," said Kenneth Wenz, M.D., a Myrtle Beach SC pain specialist and anesthesiologist. "It's no surprise that the device can confirm a palpated trigger point quite easily. However, I find it interesting that the device identifies painful muscle regions that are not palpated by traditional exam. For example, I had an elderly gentleman who has had chronic neck pain for years. He has had surgery, facet joint injections, medications and physical therapy but just has not had any relief of the pain. He pointed to the cervical paraspinous region as the source of the discomfort. However, when I used the MPDD I was able to identify painful muscles 3cm lateral to where he was pointing. I injected this region and started him on appropriate home exercises. He is now starting to notice relief." Said Dr. Wenz. "I had another patient with low back pain who was scheduled to see me for injections into the joints of the back. She had had good relief with these injections in the past. However she was frustrated that she had developed right inguinal (groin) pain and had been dealing with it for months. I was unable to palpate any trigger points. I then used the MPDD on her back and gluteal region and identified a tender muscle over a gluteal multifidi muscle. As I was stimulating the muscle the patient responded with "That's it!" I injected the muscle and within five minutes her inguinal pain was gone. Needless to say she was very happy (and so was I)."

Patients are also reporting their success with MPDD: "I've been suffering from back pain for years. In addition to bulging disc issues, I also have severe trigger point pain in my back as well. I was really excited when I first learned of the MPDD device and knew that I had to give it a try ASAP." Says Stephen Freeman of Winston-Salem, NC. "My wife is an orthopedic nurse at a local hospital and accompanied me to my appointment. She was amazed by the device and couldn't wait to get back to work and share her experience with the MPDD to the Neuro doctors she works with regularly. She felt that this device could help eliminate 1,000's of needless ineffective back surgeries. I explained to Dr. Wenz that I've had trigger point injections in the past and they were very ineffective as the doctor just randomly injected my back with a steroid. Dr. Wenz explained that before the MPDD, that was the only way to approach muscle pain. I am really excited about my future now. It's been quite depressing living with back pain for so long. My wife was moved to tears to see me experiencing relief."

People can learn more about EPGL Medical technology by attending the "7 Days in April" Conference Call Series starting Wednesday April 24, 2013 at 6:00PM Eastern. The series runs seven consecutive nights through Tuesday April 30, 2013 and attendance is first-come, first-served up to 100 attendees each night. Call 605-475-4000. Enter Code 475116# .

About EP Global Communications, Inc. / EPGL Medical 
EP Global Communications, Inc. is a medical device manufacturer and marketing company with exclusive rights to a new FDA 510k cleared medical device called the Muscle Pain Detection Device (MPDD). The MPDD is a revolutionary new tool for the treatment of muscular originated pain in the human body. In addition, EPGL Medical has Acquired a new BioMEMS technology platform for medical device development called "TopSpin".

EP Global Communications Inc. (EPGL) Stock Research Links

EPGL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hugel's Sales Climb Despite Changes in Sales Models

Updated Category News Views 97

Hugel's Financial Fortunes in a Shifting Landscape Who would've thought? That’s the vibe hugging the numbers Hugel Inc. just dropped. Their performance for the first three quarters of 2026 is in the books, and results show consolidated net sales climbing 15% year-on-year. Just how did they pull this rabbit out of the hat? Let's dissect this a bit. Cracking the Code of...

Continue Reading
Are BWIN, LFCR, PCRX Shareholder Deals Fair?

Updated Category News Views 100

What's Really Going On with BWIN, LFCR, and PCRX? Everyone talks about when there's smoke, there's fire. But in this case, it’s hard not to wonder if we're standing knee-deep in burning embers, or just a dusty old campfire. Halper Sadeh LLC is ringing the alarm bells for Baldwin Group, Lifecore Biomedical, and Pacira BioSciences, the trio tagged under NASDAQ: BWIN,...

Continue Reading
MRP Securities Fraud: Investors Eye Millrose Case

Updated Category News Views 104

Millrose's Troubles: A Closer Look at the Fraud Accusation Now, here's a pickle. Millrose Properties, Inc. (NYSE: MRP) has landed itself in hot water. We've got a bona fide class action lawsuit on our hands, and Schall, Brown & Schwartz LLP is waving the flag, rallying investors to step up and face the music. Turns out the company's talk might not have walked the walk...

Continue Reading
Peabody's Q3 2026: Margins Climb Despite Net Loss

Updated Category News Views 0

Tough Quarters but Promising Margins Alright, Peabody's Q3 2026 isn't the most sunshine-filled report I've laid eyes on, but it's not all shadows either. Sure, they posted a net loss of $32.8 million, better than last year's $70.1 million drain. Admit it or not, that's improvement. And yet, the real gem here is those expanding margins gleaming despite the loss-heavy...

Continue Reading
Omnissa Expands AI Sovereignty: New Markets, New Control

Updated Category News Views 41

Omnissa Rolls Out AI Sovereignty Across New Markets In the world of AI, where data is king and control is the crown, Omnissa is making bold moves with its latest expansion announcement. The company's Sovereign Solution (OSS) is now reaching into six fresh markets across Europe and Asia, offering organizations a vital grip on their digital domains like never before. Talk...

Continue Reading
UN Forum Unleashes LatAm CEO Coalition for Action

Updated Category News Views 89

Latin America Takes Center Stage When the UN turns its spotlight on a region, you know there's something afoot. Right in Montevideo, Uruguay, the United Nations Global Compact gathered a hefty crowd of over 300 leaders from diverse backgrounds—think business, finance, government, and academia. What they were brewing wasn’t just talk; it was about driving real change...

Continue Reading
Lincoln Index Highlights Growth, But Risks Linger

Updated Category News Views 130

Private Market Dynamics: A Mixed Bag in Q3 The Lincoln Private Market Index (LPMI) is giving us quite the mixed message this quarter. Up by 2.8%, the index is applauding earnings growth in private companies. Not too shabby, right? Yet, let's not pop the champagne just yet. It's not all sunshine and roses—credit risk clouds are looming large. Steady Performers, but Not...

Continue Reading
Lumentum Holders Question Marvell Deal Fairness: Legal Eyes

Updated Category News Views 82

What's Brewing with Lumentum and Marvell? There's no denying the chatter on Wall Street when there's a potential shake-up, especially with a big merger at stake. We're staring down the barrel of an investigation concerning Lumentum Holdings Inc. (NASDAQ: LITE) and Marvell Technology, Inc.'s deal. The M&A Class Action Firm, helmed by Juan Monteverde, is the name leading...

Continue Reading
Fluence Energy Faces Legal Trouble: A Closer Look

Updated Category News Views 31

Fluence Energy's Legal Tangle: What It Means for Investors You ever get that gut punch feeling when a company you’re watching stumbles? Well, Fluence Energy, Inc. (NASDAQ: FLNC) seems to have handed that to its shareholders lately. There's a class action lawsuit out there that’s got investors not only scratching their heads but also reaching for their phones. The...

Continue Reading
EXPO 2027 Belgrade: Serbia's Tourism Game-Changer?

Updated Category News Views 104

An Unexpected Stage: Belgrade's Big Show Well, who's betting on Belgrade making waves in the global travel scene? EXPO 2027 is shaping up to do just that, and it’s taking the scenic route. Serbia, a country not always on the grand tourist itineraries, could finally hog the spotlight come 2027. Under the banner of 'Play for Humanity: Sport and Music for All,' they're...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Latest Trends in Alcohol Policy and Health Advances

Updated Category News Views 436

Exploring the Latest Trends in Alcohol Policy and Health Advances Alcohol Justice has unveiled its February 2025 eNews, delivering a thorough overview of significant news, research, and advocacy surrounding the effects of alcohol on communities and public health. This month’s publication emphasizes vital advancements in the sphere of alcohol policy, paying close...

Continue Reading
Explore the Exciting New Manor Collection at Sereno Canyon

Updated Category News Views 273

Announcing the Grand Opening of the Manor Collection Exciting news is on the horizon as Toll Brothers, Inc. (NYSE:TOL), the nation’s leading luxury home builder, proudly presents the grand opening of its new Manor Collection at Sereno Canyon. This exceptional community is nestled in the breathtaking landscape of Scottsdale and offers residents a blend of luxury,...

Continue Reading
Federal Home Loan Bank of Boston Reports Strong Financial Results

Updated Category News Views 170

Federal Home Loan Bank of Boston Reports 2024 Results The Federal Home Loan Bank of Boston declared its preliminary financial results for the fourth quarter and the year 2024. The Bank reported a significant net income of $82.1 million for the last quarter of 2024, contributing to an impressive annual total of $290.5 million. These results are expected to be highlighted...

Continue Reading
Understanding the Rising Short Interest in IBM Stock

Updated Category News Views 133

Understanding the Rising Short Interest in IBM Stock IBM's short interest has significantly increased, recently rising by 12.5%. Currently, there are 23.16 million shares that have been sold short, representing 2.52% of the total shares available for trading. With this level of short interest, it would take traders approximately 5.94 days to cover their short positions...

Continue Reading
AlphaTON and ADDRI Join Forces for Mesothelioma Clinical Research

Updated Category News Views 144

Exciting New Clinical Trial Initiative for Mesothelioma AlphaTON Capital Corp (NASDAQ: ATON) has made a significant stride in the fight against mesothelioma by partnering with Australia's Asbestos and Dust Diseases Research Institute (ADDRI). Together, they are setting the stage for an investigator-initiated clinical trial to evaluate TT-4, a promising selective A2B...

Continue Reading